{"transactions":[{"id":710497,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:33:49.000Z","date":"2026-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7397,"price":4.06,"value":30031.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":372406,"source":{"system":"sec-edgar","filing":"0001470831-26-000705","document":"wk-form4_1783974826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000705/wk-form4_1783974826.xml","form_type":"4"}},{"id":710496,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:33:49.000Z","date":"2026-07-10","kind":"exercise","planned":false,"acquired":true,"shares":15325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023."}],"balance_after":379803,"source":{"system":"sec-edgar","filing":"0001470831-26-000705","document":"wk-form4_1783974826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000705/wk-form4_1783974826.xml","form_type":"4"}},{"id":895877,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":16579,"price":1.89,"value":31334.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":379803,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":895876,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":30950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 14, 2024 and February 18, 2025."}],"balance_after":396382,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":895875,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T22:04:51.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":396382,"source":{"system":"sec-edgar","filing":"0001470831-26-000176","document":"wk-form4_1771452289.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000176/wk-form4_1771452289.xml","form_type":"4"}},{"id":936818,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-16T21:27:58.000Z","date":"2026-01-16","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":2.22,"value":22200.0,"ownership":{"direct":true},"balance_after":156382,"source":{"system":"sec-edgar","filing":"0001470831-26-000045","document":"wk-form4_1768598875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000147083126000045/wk-form4_1768598875.xml","form_type":"4"}},{"id":1087235,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-15T13:00:15.000Z","date":"2025-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7382,"price":1.99,"value":14690.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":166382,"source":{"system":"sec-edgar","filing":"0001662579-25-000057","document":"wk-form4a_1752584408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000057/wk-form4a_1752584408.xml","form_type":"4/A","original_submission_date":"2025-07-14"}},{"id":1087234,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-15T13:00:15.000Z","date":"2025-07-10","kind":"exercise","planned":false,"acquired":true,"shares":15325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in  Table I of the Form 4 filed by the Reporting Person on July 12, 2023."}],"balance_after":173764,"source":{"system":"sec-edgar","filing":"0001662579-25-000057","document":"wk-form4a_1752584408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000057/wk-form4a_1752584408.xml","form_type":"4/A","original_submission_date":"2025-07-14"}},{"id":1087901,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-14T20:19:30.000Z","date":"2025-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":7382,"price":1.99,"value":14690.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":166382,"source":{"system":"sec-edgar","filing":"0001662579-25-000055","document":"wk-form4_1752524362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000055/wk-form4_1752524362.xml","form_type":"4"}},{"id":1263308,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":130600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":130600,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":130600},"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1263307,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5145,"price":3.18,"value":16361.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":173764,"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1263306,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-18T21:54:28.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":87100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":178909,"source":{"system":"sec-edgar","filing":"0001662579-25-000014","document":"wk-form4_1739915661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257925000014/wk-form4_1739915661.xml","form_type":"4"}},{"id":1455864,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-07-11T20:16:27.000Z","date":"2024-07-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":6191,"price":5,"value":30955.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units (\"RSUs\") and does not represent a sale by the Reporting Person."}],"balance_after":91809,"source":{"system":"sec-edgar","filing":"0001662579-24-000066","document":"wk-form4_1720728978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257924000066/wk-form4_1720728978.xml","form_type":"4"}},{"id":1640647,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T22:08:07.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":165300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in sixteen equal quarterly installments following the grant date, with the first installment vesting on May 14, 2024."}],"balance_after":165300,"derivative":{"exercise_price":7.31,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":165300},"source":{"system":"sec-edgar","filing":"0001662579-24-000019","document":"wk-form4_1708034873.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257924000019/wk-form4_1708034873.xml","form_type":"4"}},{"id":1640646,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-15T22:08:07.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2025."}],"balance_after":98000,"source":{"system":"sec-edgar","filing":"0001662579-24-000019","document":"wk-form4_1708034873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257924000019/wk-form4_1708034873.xml","form_type":"4"}},{"id":1830812,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-12T20:06:23.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":276000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on July 10, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":276000,"derivative":{"exercise_price":3.5,"expiration_date":"2033-07-09","underlying":"Common Stock","underlying_shares":276000},"source":{"system":"sec-edgar","filing":"0001662579-23-000074","document":"wk-form4_1689192375.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257923000074/wk-form4_1689192375.xml","form_type":"4"}},{"id":1830811,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":30762,"kind":"person","name":"REYNO LEONARD","position":1,"cik":"0001528716","reported_name":"REYNO LEONARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-07-12T20:06:23.000Z","date":"2023-07-10","kind":"grant","planned":false,"acquired":true,"shares":61300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on July 10, 2024, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":61300,"source":{"system":"sec-edgar","filing":"0001662579-23-000074","document":"wk-form4_1689192375.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528716/000166257923000074/wk-form4_1689192375.xml","form_type":"4"}}]}